Munira A. Basrai
Munira A. Basrai is a renowned geneticist and cancer researcher currently working at the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH). Her research primarily focuses on understanding the molecular mechanisms that lead to the development of cancer, particularly breast cancer and prostate cancer.
Early Life and Education[edit | edit source]
Munira A. Basrai was born and raised in India. She completed her undergraduate studies in biology at the University of Delhi, before moving to the United States for her postgraduate studies. She earned her Ph.D. in molecular biology from the University of California, Los Angeles (UCLA).
Career and Research[edit | edit source]
After completing her Ph.D., Basrai joined the National Cancer Institute as a postdoctoral fellow. She later became a tenure-track investigator and currently serves as a senior investigator in the Genetics Branch of the NCI.
Basrai's research focuses on the genetic and molecular mechanisms that lead to the development and progression of cancer. She has made significant contributions to the understanding of the role of chromosome segregation and aneuploidy in cancer. Her work has also shed light on the function of centromeres and kinetochores in chromosome segregation.
Contributions to Science[edit | edit source]
Basrai's work has significantly advanced the understanding of the molecular mechanisms of cancer. Her research has provided insights into the role of aneuploidy in tumorigenesis and has identified potential targets for cancer therapy. Her work has been published in numerous peer-reviewed scientific journals, and she has received several awards for her contributions to cancer research.
References[edit | edit source]
External Links[edit | edit source]
- Munira A. Basrai at the National Institutes of Health
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD